Treatment Failure

12 registered clinical trials studyying Treatment Failure — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Regorafenib After Failure of Lenvatinib in Patients With Unresectable HCC: The RELEVANT-HCC Trial NCT07514429	Ju Hyun Shim	Phase 2
Not Yet Recruiting	Regorafenib After Treatment Failure of First Line Immune Checkpoint Inhibitor Treatment in Advanced Hepatocell NCT07514455	Ju Hyun Shim	Phase 2
Recruiting	Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS) NCT06717243	Oncology Center of Biochemical Education And Research	—
Active Not Recruiting	Pre-operative Characteristics for Prediction of Supraglottic Airway Failure Using Machine Learning (ERICA) NCT06617403	University Hospital Ulm	—
Completed	Incidence of the Treatment faIlure in Osteoporosis NCT05499403	Centre Hospitalier Universitaire Vaudois	—
Completed	DOAC ADRs Retrospective Study on Genetic Variations NCT04580589	Cipherome, Inc.	—
Completed	The Factors Causing Treatment Failure in Children Receiving Oxygen Therapy With High-flow Nasal Cannula NCT06146439	Dr. Behcet Uz Children's Hospital	—
Withdrawn	Safety and Immunogenicity Study of GX-70 in TB Patient NCT03159975	Yonsei University	Phase 1
Completed	RCT of Efficacy of Amoxicillin Over Ampicillin on Severe Pneumonia NCT03369093	International Centre for Diarrhoeal Disease Research, Bangladesh	N/A
Completed	Virologic Treatment Failure and Drug Resistance in HIV-infected Kenyan Children (RESPECT) NCT03120065	Rachel Vreeman, MD, MS	N/A
Completed	Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With NCT01189695	Bamrasnaradura Infectious Diseases Institute	Phase 4
Completed	Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-Infected Patients NCT00221650	University Hospital, Bordeaux	Phase 2